Former Trainee Endowed Fellowship Honoring Esmon
A $1 million gift will support graduate research in cardiovascular biology at an Oklahoma City foundation.
Updated on Oct. 8, 2026 in Heart Disease
Live Poll
Do you believe private research endowments effectively drive meaningful medical innovation for the public?
Former trainee Jun Xu has established a $1 million graduate fellowship at the Oklahoma Medical Research Foundation. The endowment honors the career and mentorship of the late scientist Charles T. Esmon.
Why it matters
The fellowship provides dedicated financial support for graduate students entering the field of cardiovascular biology. It ensures the enduring legacy of Dr. Esmon, whose work in blood coagulation helped lead to two FDA-approved drugs.
The endowment fund totals $1 million, supporting students in cardiovascular biology. Dr. Esmon's career at the foundation spanned 37 years and resulted in the development of two FDA-approved drugs.
The players
Charles T. Esmon
He was a distinguished scientist, National Academy of Sciences member, and Howard Hughes Medical Institute Investigator.
Oklahoma Medical Research Foundation
This nonprofit biomedical research institute based in Oklahoma City focuses on human diseases.
Jun Xu
He is a former trainee of Dr. Esmon who established the endowment to honor his mentor.
The details
The fellowship, officially named the Charles T. Esmon Endowed Graduate Student Fellowship in Cardiovascular Biology, was unveiled during a scientific symposium. The donation was initiated by Jun Xu, who trained under Dr. Esmon prior to the scientist's 2019 retirement.
Timeline
Charles T. Esmon retired from the Oklahoma Medical Research Foundation in 2019.
Charles T. Esmon died in May 2026 at age 79.
The fellowship was officially announced on October 5, 2026.
The Big Picture
This fellowship reinforces the long-term sustainability of the Oklahoma Medical Research Foundation's cardiovascular biology research program. It extends the foundation's scientific reach by providing a permanent funding stream for future scholars.
The fellowship directly impacts the future of medical innovation by training new scientists to combat cardiovascular disease. By supporting advanced research, the endowment aims to accelerate the discovery of treatments that could eventually reach patients.
The takeaway
Philanthropy directed at graduate fellowships creates a lasting impact by securing the next generation of scientific leadership. Donors looking to support medical progress often choose to honor their mentors to bridge the gap between historical expertise and future innovation.
Further reading
Learn more about local research efforts on the Heart Disease section of our site.
Source note: This article includes information reported by The Journal Record.
Live Poll
Do you believe private research endowments effectively drive meaningful medical innovation for the public?
